A detailed history of Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Bank & Trust CO holds 12,019 shares of LLY stock, worth $10.5 Million. This represents 7.79% of its overall portfolio holdings.

Number of Shares
12,019
Previous 12,281 2.13%
Holding current value
$10.5 Million
Previous $10.9 Billion 14.72%
% of portfolio
7.79%
Previous 8.83%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 07, 2025

SELL
$727.2 - $932.06 $190,526 - $244,199
-262 Reduced 2.13%
12,019 $9.28 Billion
Q3 2024

Oct 09, 2024

SELL
$772.14 - $960.02 $12,354 - $15,360
-16 Reduced 0.13%
12,281 $10.9 Billion
Q2 2024

Jul 08, 2024

BUY
$724.87 - $909.04 $8.91 Million - $11.2 Million
12,297 New
12,297 $11.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $827B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bank & Trust CO Portfolio

Follow Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank & Trust CO with notifications on news.